Clinical Trial Update: Comparison Between Infliximab and Adalimumab on Patients With Ulcerative Colitis

View source ↗

Summary

A completed clinical trial comparing the efficacy and safety of infliximab versus adalimumab in patients with ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Humira (adalimumab)
• Remicade (infliximab)

Snippet

Sponsor: Vastra Gotaland Region | Conditions: Ulcerative Colitis, Inflammatory Bowel Diseases | Status: COMPLETED